[1]
2026. Improvements in Sleep and Pruritus With Abrocitinib Versus Dupilumab in Patients With Moderate-to-Severe Atopic Dermatitis: Results From the JADE DARE Study. SKIN The Journal of Cutaneous Medicine. 10, 3 (May 2026), s778. DOI:https://doi.org/10.25251/03qdfm08.